Kyle Vance‐Bryan

1.1k total citations
35 papers, 886 citations indexed

About

Kyle Vance‐Bryan is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Infectious Diseases. According to data from OpenAlex, Kyle Vance‐Bryan has authored 35 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Anesthesiology and Pain Medicine and 8 papers in Infectious Diseases. Recurrent topics in Kyle Vance‐Bryan's work include Antibiotics Pharmacokinetics and Efficacy (14 papers), Anesthesia and Sedative Agents (11 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Kyle Vance‐Bryan is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (14 papers), Anesthesia and Sedative Agents (11 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Kyle Vance‐Bryan collaborates with scholars based in United States. Kyle Vance‐Bryan's co-authors include John C. Rotschafer, David R.P. Guay, Susan S. Gilliland, Keith A. Rodvold, John P. Toscano, T. A. Larson, Avi Nahum, Mark W. Garrison, Julia Moody and Steven R. Benson and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine and Journal of the American Geriatrics Society.

In The Last Decade

Kyle Vance‐Bryan

35 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Vance‐Bryan United States 15 408 314 232 148 147 35 886
Dennis J. Stalker United States 12 570 1.4× 675 2.1× 141 0.6× 173 1.2× 299 2.0× 21 1.2k
Javier Maynar Spain 21 499 1.2× 207 0.7× 267 1.2× 176 1.2× 53 0.4× 33 1.0k
Denis Bugnon France 16 395 1.0× 290 0.9× 351 1.5× 228 1.5× 179 1.2× 32 816
Kevin Watt United States 22 642 1.6× 398 1.3× 601 2.6× 83 0.6× 82 0.6× 102 2.0k
Tuuli Metsvaht Estonia 22 330 0.8× 140 0.4× 364 1.6× 91 0.6× 67 0.5× 77 1.4k
Bernard Georges France 19 359 0.9× 124 0.4× 224 1.0× 176 1.2× 46 0.3× 49 1.0k
Darwin E. Zaske United States 22 1.2k 2.9× 356 1.1× 512 2.2× 261 1.8× 220 1.5× 59 2.0k
João Pedro Baptista Portugal 12 503 1.2× 173 0.6× 321 1.4× 83 0.6× 115 0.8× 36 826
Robert E. Ariano Canada 25 799 2.0× 260 0.8× 553 2.4× 359 2.4× 230 1.6× 74 1.9k
Hussain Mulla United Kingdom 22 580 1.4× 127 0.4× 185 0.8× 34 0.2× 63 0.4× 54 1.3k

Countries citing papers authored by Kyle Vance‐Bryan

Since Specialization
Citations

This map shows the geographic impact of Kyle Vance‐Bryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Vance‐Bryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Vance‐Bryan more than expected).

Fields of papers citing papers by Kyle Vance‐Bryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Vance‐Bryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Vance‐Bryan. The network helps show where Kyle Vance‐Bryan may publish in the future.

Co-authorship network of co-authors of Kyle Vance‐Bryan

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Vance‐Bryan. A scholar is included among the top collaborators of Kyle Vance‐Bryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Vance‐Bryan. Kyle Vance‐Bryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benson, Steven R., et al.. (2000). Time to patient discontinuation of antihypertensive drugs in different classes. American Journal of Health-System Pharmacy. 57(1). 51–54. 24 indexed citations
2.
Benson, Steven R. & Kyle Vance‐Bryan. (1998). In favor of Coumadin over generic warfarin. American Journal of Health-System Pharmacy. 55(7). 727–729. 14 indexed citations
3.
Rotschafer, John C., et al.. (1997). Wide Variation in Single, Daily-Dose Aminoglycoside Pharmacokinetics in Patients with Burn Injuries. Journal of Burn Care & Rehabilitation. 18(2). 116–124. 29 indexed citations
4.
Guay, David R.P., et al.. (1996). QTc‐Interval Prolongation Associated with Slow Intravenous Erythromycin Lactobionate Infusions in Critically Ill Patients: A Prospective Evaluation and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(4). 663–674. 33 indexed citations
5.
Vance‐Bryan, Kyle, et al.. (1996). Lorazepam Stability in Parenteral Solutions for Continuous Intravenous Administration. Annals of Pharmacotherapy. 30(4). 343–346. 10 indexed citations
6.
Vance‐Bryan, Kyle, et al.. (1995). Inconsistency With Train‐of‐Four Monitoring in a Critically Ill Paralyzed Patient. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(4). 540–545. 8 indexed citations
7.
Vance‐Bryan, Kyle, et al.. (1995). Inappropriate Vancomycin Prescribing Based on Criteria from the Centers for Disease Control and Prevention. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(5). 579–585. 45 indexed citations
8.
Vance‐Bryan, Kyle, et al.. (1995). Anti-infective agents and hepatic disease. Medical Clinics of North America. 79(4). 895–917. 6 indexed citations
9.
Nahum, Avi, et al.. (1995). Prolonged Neuromuscular Blockade in Two Critically Ill Patients Treated With Atracurium. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(2). 254–259. 15 indexed citations
10.
Nahum, Avi, et al.. (1994). A Retrospective Review and Assessment of Benzodiazepines in the Treatment of Alcohol Withdrawal in Hospitalized Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 14(5). 572–578. 9 indexed citations
11.
Kelly, Kevin J., et al.. (1994). A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.. PubMed. 13(6). 647–55. 13 indexed citations
12.
Vance‐Bryan, Kyle, John C. Rotschafer, Susan S. Gilliland, et al.. (1994). A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient. Journal of Antimicrobial Chemotherapy. 33(4). 811–821. 41 indexed citations
13.
Gilliland, Susan S., et al.. (1993). A Retrospective Analysis of Long‐Term Use of Nondepolarizing Neuromuscular Blocking Agents in the Intensive Care Unit, and Guidelines for Drug Selection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 13(6). 647–655. 11 indexed citations
14.
Guay, David R.P., Kyle Vance‐Bryan, Susan S. Gilliland, Keith A. Rodvold, & John C. Rotschafer. (1993). Comparison of Vancomycin Pharmacokinetics in Hospitalized Elderly and Young Patients Using a Bayesian Forecaster. The Journal of Clinical Pharmacology. 33(10). 918–922. 44 indexed citations
15.
Gilliland, Susan S., et al.. (1993). Clostridium difficile Colonization in Residents of Long‐Term Care Facilities: Prevalence and Risk Factors. Journal of the American Geriatrics Society. 41(9). 940–946. 74 indexed citations
16.
Vance‐Bryan, Kyle, et al.. (1993). Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system. Antimicrobial Agents and Chemotherapy. 37(11). 2454–2458. 25 indexed citations
17.
Kelly, Kevin J., et al.. (1993). Response to Pancuronium after Loss of Atracurium-Induced Neuromuscular Blockade. Annals of Pharmacotherapy. 27(7-8). 862–865. 7 indexed citations
18.
Vance‐Bryan, Kyle, T. A. Larson, Mark W. Garrison, et al.. (1992). An in Vitro Pharmacodynamic Model to Simulate Antibiotic Behavior of Acute Otitis Media with Effusion. Pharmaceutical Research. 9(7). 920–924. 8 indexed citations
19.
Rotschafer, John C., et al.. (1992). Pharmacotherapy and pharmacodynamics in the management of bacterial infection.. PubMed. 32(12). 1083–8. 5 indexed citations
20.
Vance‐Bryan, Kyle, David R.P. Guay, & John C. Rotschafer. (1990). Clinical Pharmacokinetics of Ciprofloxacin. Clinical Pharmacokinetics. 19(6). 434–461. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dennis J. Stalker Breakdown of academic impact, for papers by Javier Maynar Breakdown of academic impact, for papers by Denis Bugnon Breakdown of academic impact, for papers by Kevin Watt Breakdown of academic impact, for papers by Tuuli Metsvaht Breakdown of academic impact, for papers by Bernard Georges Breakdown of academic impact, for papers by Darwin E. Zaske Breakdown of academic impact, for papers by João Pedro Baptista Breakdown of academic impact, for papers by Robert E. Ariano Breakdown of academic impact, for papers by Hussain Mulla
Rankless by CCL
2026